Patient Activity Report definition

Patient Activity Report means a report generated by CURES of the Controlled Substances history of a patient. The Patient Activity Report includes the patient last name, patient first name, patient middle initial, patient date of birth, patient gender, patient address, compact status, number of prescriptions, date filled, date sold, drug name, drug form, drug strength, quantity, days supply, species code, prescription number, refill number, number of authorized refills, payment method, prescriber name, prescriber DEA Number, pharmacy name, pharmacy number, and prescription form serial number.
Sample 1Sample 2

Examples of Patient Activity Report in a sentence

  • Select the Prescriber-User on whose behalf the Delegate is initiating the Patient Activity Report.

  • A Patient Activity Report is available in the Web-Based Application or the Information Exchange Web Service.

  • Select the Pharmacist-User on whose behalf the Delegate is initiating the Patient Activity Report.

  • In addition, activate the reasons for involuntary discharges in SIMS and add the reasons for involuntary discharge to the Patient Activity Report.

  • The authority to generate an interstate Patient Activity Report is provided in HSC 11165(h).

  • The purpose of subdivision (d)(3) is to specify that an interstate Patient Activity Report is available in the Web-Based Application.

  • The work has been conducted as a common effort of CERN and FNAL cryogenics teams.

  • Patient Activity Report (PAR):• One-page document that is completed by the practitioner twice a year that captures the previous six-month client payer source data for both the practice site and the individual practitioner’s clients/patients (Jan.

  • To request a Patient Activity Report, an Interstate Prescriber or Interstate Pharmacist mustagree to the Terms and Conditions of CURES.Note: Authority cited: Section 11165, Health and Safety Code.

  • Long-Term Care Patient Activity Report (SAMPLE)The form is used to notify the LDSS of any action that is required regarding a Medical Assistance payment to the LTCF.

Related to Patient Activity Report

  • Feasibility Report means a detailed written report of the results of a comprehensive study on the economic feasibility of placing the Property or a portion thereof into Commercial Production and shall include a reasonable assessment of the mineral ore reserves and their amenability to metallurgical treatment, a description of the work, equipment and supplies required to bring the Property or a portion thereof into Commercial Production and the estimated cost thereof, a description of the mining methods to be employed and a financial appraisal of the proposed operations supported by an explanation of the data used therein;

  • Development Activity means any activity defined as Development which will necessitate a Floodplain Development Permit. This includes buildings, structures, and non-structural items, including (but not limited to) fill, bulkheads, piers, pools, docks, landings, ramps, and erosion control/stabilization measures.

  • Activity Material means any Material, other than Reporting Material, created or developed by the Grantee as a result of the Activity and includes any Existing Material that is incorporated in or supplied with the Activity Material.

  • Project Management Report means each report prepared in accordance with Section 4.02 of this Agreement;

  • Rapidly report means within 72 hours of discovery of any cyber incident.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Rapid(ly) report(ing means within 72 hours of discovery of any cyber incident.

  • Sales Report means a report in substantially the form set forth in Exhibit B “Royalty Report Form”.

  • Project Report means a summary statement of the likely environmental effects of a proposed development referred to in section 58;

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Development Activities means those activities which are normally undertaken for the development, construction, repair, renovation, rehabilitation or conversion of buildings for residential purposes, including the acquisition of property;

  • Development Report means a written account of Licensee’s progress under the Development Plan having at least the information specified on Appendix B to this Agreement, and shall be sent to the address specified on Appendix B.

  • Royalty Report shall have the meaning set forth in Section 7.1.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Day reporting means a program of enhanced supervision

  • Diagnostic clinical procedures manual means a collection of written procedures that describes each method (and other instructions and precautions) by which the licensee performs diagnostic clinical procedures; where each diagnostic clinical procedure has been approved by the authorized user and includes the radiopharmaceutical, dosage, and route of administration.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Extracurricular activity means any optional, noncredit, educational or

  • Phase IV Clinical Trial means a product support clinical trial of a Product commenced after receipt of Regulatory Approval in the country where such trial is conducted. A Phase IV Clinical Trial may include epidemiological studies, modeling and pharmacoeconomic studies, and investigator-sponsored clinical trials studying Product that are approved by BMS and that otherwise fit the foregoing definition.

  • Research record means any data, document, computer file, computer diskette, or any other written or non-written account or object that reasonably may be expected to provide evidence or information regarding the proposed, conducted, or reported research that constitutes the subject of an allegation of research misconduct. A research record includes, but is not limited to, grant or contract applications, whether funded or unfunded; grant or contract progress and other reports; laboratory notebooks; notes; correspondence; videos; photographs; X-ray film; slides; biological materials; computer files and printouts; manuscripts and publications; equipment use logs; laboratory procurement records; animal facility records; human and animal subject protocols; consent forms; medical charts; and patient research files.

  • Phase I Trial means a clinical trial of a Licensed Product in human patients conducted primarily for the purpose of determining the safety, tolerability and preliminary activity of the Licensed Product, including, without limitation, for determining the maximum tolerated dose, or optimal dose. For purposes of this Agreement, a Phase I trial shall specifically exclude a study in healthy volunteers.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.